pCR2.1 Clover-LMNA Donor Citations (4)
Originally described in: Nuclear domain 'knock-in' screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing.Pinder J, Salsman J, Dellaire G Nucleic Acids Res. 2015 Oct 30;43(19):9379-92. doi: 10.1093/nar/gkv993. Epub 2015 Oct 1. PubMed Journal
Articles Citing pCR2.1 Clover-LMNA Donor
| Articles |
|---|
| PML isoform expression and DNA break location relative to PML nuclear bodies impacts the efficiency of homologous recombination. Attwood KM, Salsman J, Chung D, Mathavarajah S, Van Iderstine C, Dellaire G. Biochem Cell Biol. 2019 Oct 31. doi: 10.1139/bcb-2019-0115. PubMed |
| A Disease-Causing Single Amino Acid Deletion in the Coiled-Coil Domain of RAD50 Impairs MRE11 Complex Functions in Yeast and Humans. Chansel-Da Cruz M, Hohl M, Ceppi I, Kermasson L, Maggiorella L, Modesti M, de Villartay JP, Ileri T, Cejka P, Petrini JHJ, Revy P. Cell Rep. 2020 Dec 29;33(13):108559. doi: 10.1016/j.celrep.2020.108559. PubMed |
A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells.
Carusillo A, Haider S, Schafer R, Rhiel M, Turk D, Chmielewski KO, Klermund J, Mosti L, Andrieux G, Schafer R, Cornu TI, Cathomen T, Mussolino C.
Nucleic Acids Res. 2023 May 22;51(9):4660-4673. doi: 10.1093/nar/gkad255.
PubMed
Associated Plasmids |
| Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer. Zhu Y, Liu Z, Gui L, Yun W, Mao C, Deng R, Yao Y, Yu Q, Feng J, Ma H, Bao W. NPJ Breast Cancer. 2023 May 8;9(1):34. doi: 10.1038/s41523-023-00540-3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.